ConvaTec Group Plc Stock

Equities

CTEC

GB00BD3VFW73

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 11:35:09 2024-05-31 am EDT 5-day change 1st Jan Change
248.6 GBX -0.48% Intraday chart for ConvaTec Group Plc -0.96% +1.80%
Sales 2024 * 2.27B Sales 2025 * 2.4B Capitalization 6.47B
Net income 2024 * 191M Net income 2025 * 245M EV / Sales 2024 * 3.34 x
Net Debt 2024 * 1.09B Net Debt 2025 * 903M EV / Sales 2025 * 3.07 x
P/E ratio 2024 *
33.6 x
P/E ratio 2025 *
26.1 x
Employees 10,136
Yield 2024 *
2.03%
Yield 2025 *
2.21%
Free-Float 80.35%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on ConvaTec Group Plc

1 day-0.48%
1 week-0.96%
1 month-0.56%
3 months+0.97%
6 months+10.59%
Current year+1.80%
More quotes
1 week
245.80
Extreme 245.8
256.00
1 month
244.40
Extreme 244.4
266.40
Current year
232.40
Extreme 232.4
295.20
1 year
195.10
Extreme 195.1
295.20
3 years
165.30
Extreme 165.3
295.20
5 years
138.00
Extreme 138
295.20
10 years
113.25
Extreme 113.25
349.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 19-09-29
Director of Finance/CFO 60 22-01-30
Chief Operating Officer - 22-03-31
Members of the board TitleAgeSince
Director/Board Member 58 22-01-31
Chairman 76 19-09-29
Director/Board Member 69 17-08-13
More insiders
Date Price Change Volume
24-05-31 248.6 -0.48% 6,452,857
24-05-30 249.8 +0.48% 2,376,110
24-05-29 248.6 -1.19% 10,400,960
24-05-28 251.6 +0.24% 4,777,130
24-05-24 251 -0.24% 3,137,526

Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT

More quotes
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, incontinence and critical care. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (32.5%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (28.4%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence and critical care (21.3%); - infusion (21.3%) ; - other (0.5%). At the end of 2023, the group operated 9 production sites worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (30.2%), Americas (55.4%) and Asia/Pacific (14.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
3.163 USD
Average target price
3.926 USD
Spread / Average Target
+24.12%
Consensus